Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
106M
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
25.8M
-
Shares change
-
-1.13M
-
Total reported value, excl. options
-
$322M
-
Value change
-
-$12.8M
-
Number of buys
-
27
-
Number of sells
-
-25
-
Price
-
$12.49
Significant Holders of Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) as of Q1 2019
72 filings reported holding RCUS - Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q1 2019.
Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.8M shares
of 106M outstanding shares and own 24.39% of the company stock.
Largest 10 shareholders include Alphabet Inc. (5.05M shares), WELLINGTON MANAGEMENT GROUP LLP (4.26M shares), Svennilson Peter (3.54M shares), BVF INC/IL (2.81M shares), BlackRock Inc. (1.83M shares), Foresite Capital Management III, LLC (1.37M shares), VANGUARD GROUP INC (1.16M shares), EcoR1 Capital, LLC (990K shares), STATE STREET CORP (541K shares), and JANUS HENDERSON GROUP PLC (507K shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.